Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma

Jonathon W. Senefeld(University of Illinois Urbana-Champaign), Michael J. Joyner(WinnMed), Matthew N.P. Vogt(Johns Hopkins University), Chad C. Wiggins(Johns Hopkins University), Andrew J. Clayburn(Johns Hopkins University), Camille M. van Buskirk(Johns Hopkins University), Stephen A. Klassen(Brock University), Allan M. Klompas(Mayo Clinic in Florida), Rickey E. Carter(Mayo Clinic in Florida), Katelyn A. Bruno(Mayo Clinic in Florida), M. Petersen(Mayo Clinic in Arizona), Emily R. Whelan(Mayo Clinic in Florida), John R.A. Shepherd(Johns Hopkins University), Kylie J. Andersen(Johns Hopkins University), James R. Stubbs(Johns Hopkins University), Jeffrey L. Winters(Mayo Clinic), Michael A. Golafshar, Janis E. Blair(Mayo Clinic Hospital), Noud van Helmond(Cooper University Hospital), Philippe R. Bauer(Mayo Clinic in Florida), Robert F. Rea(Harvard–MIT Division of Health Sciences and Technology), Vitaly Herasevich(Mayo Clinic in Florida), Matthew A. Sexton(Johns Hopkins University), Katie L. Kunze(Mayo Clinic in Arizona), R. Scott Wright(Pacific Heart Institute), Patrick W. Johnson(Mayo Clinic in Florida), Kathryn F. Larson(Johns Hopkins University), Sarah E. Baker(Johns Hopkins University), Juan G. Ripoll(Johns Hopkins University), Katherine Wright(Northwestern University), Nicole Verdun(Center for Biologics Evaluation and Research), Riley J. Regimbal(Johns Hopkins University), Nigel Paneth, Arturo Casadevall(Johns Hopkins University), DeLisa Fairweather(Mayo Clinic), Matthew Buras, Joshua J. Dennis(Johns Hopkins University), Joel T. Greenshields(Indiana University Bloomington), Juan C. Diaz Soto(Johns Hopkins University), Peter Marks(Center for Biologics Evaluation and Research)
medRxiv
April 11, 2021
Cited by 7


Related Papers